Protagonist Therapeutics, Inc. (PTGX) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Protagonist Therapeutics, Inc. · Health Care · ref. ETF XLV · 63 calls · price $149.5
What the company does: Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States.
📈 Protagonist Therapeutics, Inc. (PTGX) stock price
$149.5+157.1% over range
Aug 28, 25low $56.19 · high $158.62Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 10 analysts
📊 JPI status : Protagonist Therapeutics, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 PTGX price target & analyst consensus — price $150
The price target · all analysts combined (10 targets)
Highest target · 1 firm of 10$186+24.4%
Median target · of 10 targets$161.5+8.0%
Lowest target · 1 firm of 10$106-29.1%
Current price$149.5
Where these 10 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
660%
$153 ↔ $186
Below
440%
$106 ↔ $137
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 10 ratings (last 6 months)
Strong Buy00%
Buy10100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 PTGX price target all
All 63 calls, one by one, with our verdict on each firm.
→ See all 63 targets, analyst by analyst💡 The best analysts on PTGX most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in PTGX? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Protagonist Therapeutics, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on PTGX
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Piper Sandler ↗ | 100% | +105.0% | 3 |
| Wedbush ↗ | 100% | +88.1% | 2 |
| Nomura | 100% | +57.6% | 2 |
| Truist Securities ↗ | 100% | +47.0% | 2 |
| HC Wainwright & Co. ↗ | 87% | +64.3% | 31 |
| JP Morgan ↗ | 86% | +69.0% | 7 |
| JMP Securities | 71% | +40.9% | 14 |
| BMO Capital ↗ | 62% | +14.5% | 8 |
| BTIG ↗ | 50% | -1.1% | 4 |
| Stifel ↗ | 50% | -16.0% | 2 |
See the other 2 firms
| Northland Capital Markets ↗ | 0% | -75.8% | 2 |
| SVB Leerink | 33% | +13.3% | 6 |
📊 What $1,000 invested in Protagonist Therapeutics, Inc. would be worth › open the full page
In short — $1,000 invested in Protagonist Therapeutics, Inc. 10 years ago would be worth $6,212 today, i.e. +20%/yr on average. Best year: 2020 (+186%), worst: 2022 (-68%). Price performance, excluding dividends.
If I'd invested $1,000 in Protagonist Therapeutics, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $3,401 | +240% |
| 3 years ago | $12,032 | +1103% |
| 5 years ago | $6,511 | +551% |
Return by year (Protagonist Therapeutics, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +50% | $1,503 (+50%) |
| 2025 | +126% | $3,401 (+240%) |
| 2024 | +68% | $5,725 (+472%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Protagonist Therapeutics, Inc.
Loading news…
📋 All analyst calls on PTGX
Filtered on — · ✕ show all
BMO Capital ↗
Aug 17, 26
▲ Outperform · 🎯$178
Price at call : $158.62 — upside +12%
Today : $149.5 — upside +19%
🎯 on PTGX : 63% (8 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Aug 17, 27
matures : Aug 17, 27
Truist Securities ↗
Aug 10, 26
▲ Buy · 🎯$170
Price at call : $148.29 — upside +15%
Today : $149.5 — upside +14%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
▲ Outperform · 🎯$173
Price at call : $148.29 — upside +17%
Today : $149.5 — upside +16%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
Goldman Sachs ↗
Aug 10, 26
▲ Buy · 🎯$186
Price at call : $150 — upside +24%
Today : $149.5 — upside +24%
🎯 on PTGX : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
▲ Buy · 🎯$175
Price at call : $145.87 — upside +20%
Today : $149.5 — upside +17%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Overweight · 🎯$153
Price at call : $145.87 — upside +5%
Today : $149.5 — upside +2%
🎯 on PTGX : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Overweight · 🎯$151
Price at call : $131.27 — upside +15%
Today : $149.5 — upside +1%
🎯 on PTGX : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Truist Securities ↗
Jul 7, 26
▲ Buy · 🎯$145
Price at call : $140.85 — upside +3%
Today : $149.5 — upside -3%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
See the other 55 calls, newest to oldest
Citizens
May 6, 26
▲ Market Outperform · 🎯$137
Price at call : $98.85 — upside +39%
Today : $149.5 — upside -8%
🎯 on PTGX : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Outperform · 🎯$118
Price at call : $103.97 — upside +13%
Today : $149.5 — upside -21%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Truist Securities ↗
Apr 15, 26
▲ Buy · 🎯$121
Price at call : $103.73 — upside +17%
Today : $149.5 — upside -19%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
Clear Street
Apr 7, 26
▲ Buy · 🎯$116
Price at call : $103.75 — upside +12%
Today : $149.5 — upside -22%
🎯 on PTGX : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Apr 7, 27
matures : Apr 7, 27
Leerink Partners ↗
Mar 19, 26
▲ Outperform · 🎯$110
Price at call : $98.87 — upside +11%
Today : $149.5 — upside -26%
🎯 on PTGX : no call matured yet · 📊 on Health : 50% · -5.3% (10 calls)
in progress (365j)
matures : Mar 19, 27
matures : Mar 19, 27
▲ Overweight · 🎯$106
Price at call : $98.87 — upside +7%
Today : $149.5 — upside -29%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Mar 19, 27
matures : Mar 19, 27
▲ Buy · 🎯$125
Price at call : $98.87 — upside +26%
Today : $149.5 — upside -16%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Mar 19, 27
matures : Mar 19, 27
▲ Overweight · 🎯$119
Price at call : $98.87 — upside +20%
Today : $149.5 — upside -20%
🎯 on PTGX : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Mar 19, 27
matures : Mar 19, 27
Goldman Sachs ↗
Mar 3, 26
■ Neutral neutral · not a buy · 🎯$95
Price at call : $94.83 — gap to target +0%
Today : $149.5 — gap to target -36%
🎯 on PTGX : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Mar 3, 27
matures : Mar 3, 27
▲ Buy · 🎯$100
Price at call : $92.08 — upside +9%
Today : $149.5 — upside -33%
🎯 on PTGX : no call matured yet · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Overweight · 🎯$113
Price at call : $92.08 — upside +23%
Today : $149.5 — upside -24%
🎯 on PTGX : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Citizens
Feb 26, 26
▲ Market Outperform · 🎯$112
Price at call : $92.08 — upside +22%
Today : $149.5 — upside -25%
🎯 on PTGX : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$118
Price at call : $85.59 — upside +38%
Today : $149.5 — upside -21%
🎯 on PTGX : no call matured yet · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
HC Wainwright & Co. ↗
Jan 30, 26
▲ Buy · 🎯$117
Price at call : $83.05 — upside +41%
Today : $149.5 — upside -22%
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
Truist Securities ↗
Jan 5, 26
▲ Buy · 🎯$110
Price at call : $82.27 — upside +34%
Today : $149.5 — upside -26%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
▲ Overweight · 🎯$108
Price at call : $85.79 — upside +26%
Today : $149.5 — upside -28%
🎯 on PTGX : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
▲ Buy · 🎯$115
Price at call : $88.56 — upside +30%
Today : $149.5 — upside -23%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Dec 8, 26
matures : Dec 8, 26
▲ Buy · 🎯$98
Price at call : $85.56 — upside +15%
Today : $149.5 — upside -34%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
▲ Overweight · 🎯$81
Price at call : $83.23 — upside -3%
Today : $149.5 — upside -46%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Overweight · 🎯$88
Price at call : $83.23 — upside +6%
Today : $149.5 — upside -41%
🎯 on PTGX : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Citizens
Nov 7, 25
▲ Market Outperform · 🎯$102
Price at call : $79.54 — upside +28%
Today : $149.5 — upside -32%
🎯 on PTGX : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Truist Securities ↗
Oct 28, 25
▲ Buy · 🎯$88
Price at call : $76.69 — upside +15%
Today : $149.5 — upside -41%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
▲ Outperform · 🎯$86
Price at call : $78.51 — upside +10%
Today : $149.5 — upside -42%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
▲ Buy · 🎯$82
Price at call : $78.51 — upside +4%
Today : $149.5 — upside -45%
🎯 on PTGX : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
▲ Buy · 🎯$96
Price at call : $76.72 — upside +25%
Today : $149.5 — upside -36%
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Oct 17, 26
matures : Oct 17, 26
HC Wainwright & Co. ↗
Oct 8, 25
▲ Buy · 🎯$80
Price at call : $65.3 — upside +23%
Today : $149.5 — upside -46%
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
HC Wainwright & Co. ↗
Sep 17, 25
▲ Buy · 🎯$80
Price at call : $62.14 — upside +29%
Today : $149.5 — upside -46%
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Sep 17, 26
matures : Sep 17, 26
▲ Overweight · 🎯$72
Price at call : $59.22 — upside +22%
Today : $149.5 — upside -52%
🎯 on PTGX : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Sep 17, 26
matures : Sep 17, 26
Leerink Partners ↗
Sep 12, 25
▲ Outperform · 🎯$73
Price at call : $58.86 — upside +24%
Today : $149.5 — upside -51%
🎯 on PTGX : no call matured yet · 📊 on Health : 50% · -5.3% (10 calls)
in progress (365j)
matures : Sep 12, 26
matures : Sep 12, 26
JMP Securities
Aug 7, 25
▲ Market Outperform · 🎯$69
Price at call : $51.07 — upside +35%
Today : $149.5 — upside -54%
Expected +35% · Actual +194% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (1 call matured) · 📊 unranked overall
+193.7%
stock +194% · XLV +29%
matured Aug 7, 26
▲ Buy · 🎯$72
Price at call : $55.21 — upside +30%
Today : $149.5 — upside -52%
Expected +30% · Actual +102% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
+101.8%
stock +102% · XLV +13%
matured Jun 17, 26
HC Wainwright & Co. ↗
Jun 3, 25
▲ Buy · 🎯$80
Price at call : $51.06 — upside +57%
Today : $149.5 — upside -46%
Expected +57% · Actual +87% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+86.9%
stock +87% · XLV +11%
matured Jun 3, 26
HC Wainwright & Co. ↗
May 19, 25
▲ Buy · 🎯$80
Price at call : $45.57 — upside +76%
Today : $149.5 — upside -46%
Expected +76% · Actual +116% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+115.9%
stock +116% · XLV +10%
matured May 19, 26
HC Wainwright & Co. ↗
Apr 10, 25
▲ Buy · 🎯$80
Price at call : $42.62 — upside +88%
Today : $149.5 — upside -46%
Expected +88% · Actual +129% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+128.9%
stock +129% · XLV +8%
matured Apr 10, 26
▲ Outperform · 🎯$70
Price at call : $48.36 — upside +45%
Today : $149.5 — upside -53%
Expected +45% · Actual +107% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 35.8% · +3.2% (53 calls)
+106.5%
stock +107% · XLV -2%
matured Mar 28, 26
Truist Securities ↗
Mar 11, 25
▲ Buy · 🎯$76
Price at call : $57.65 — upside +32%
Today : $149.5 — upside -49%
Expected +32% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 37.6% · -0.8% (165 calls)
+65.5%
stock +66% · XLV +4%
matured Mar 11, 26
BMO Capital ↗
Mar 11, 25
▲ Outperform · 🎯$72
Price at call : $59.76 — upside +20%
Today : $149.5 — upside -52%
Expected +20% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 63% (8 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+61.5%
stock +61% · XLV +5%
matured Mar 11, 26
HC Wainwright & Co. ↗
Mar 11, 25
▲ Buy · 🎯$80
Price at call : $59.76 — upside +34%
Today : $149.5 — upside -46%
Expected +34% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+61.5%
stock +61% · XLV +5%
matured Mar 11, 26
Citizens Capital Markets
Mar 10, 25
▲ Market Outperform · 🎯$61
Price at call : $59.76 — upside +2%
Today : $149.5 — upside -59%
Expected +2% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (1 call matured) · 📊 unranked overall
+61.5%
stock +61% · XLV +5%
matured Mar 10, 26
HC Wainwright & Co. ↗
Mar 10, 25
▲ Buy · 🎯$54
Price at call : $55.95 — upside -3%
Today : $149.5 — upside -64%
Expected -3% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+73.5%
stock +73% · XLV +4%
matured Mar 10, 26
▲ Overweight · 🎯$57
Price at call : $38.66 — upside +47%
Today : $149.5 — upside -62%
Expected +47% · Actual +145% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (1 call matured) · 📊 on Health : 49.3% · +6.9% (146 calls)
+145.3%
stock +145% · XLV +6%
matured Mar 4, 26
HC Wainwright & Co. ↗
Mar 3, 25
▲ Buy · 🎯$54
Price at call : $38.66 — upside +40%
Today : $149.5 — upside -64%
Expected +40% · Actual +145% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+145.3%
stock +145% · XLV +6%
matured Mar 3, 26
HC Wainwright & Co. ↗
Feb 24, 25
▲ Buy · 🎯$54
Price at call : $36 — upside +50%
Today : $149.5 — upside -64%
Expected +50% · Actual +143% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+142.8%
stock +143% · XLV +7%
matured Feb 24, 26
HC Wainwright & Co. ↗
Feb 7, 25
▲ Buy · 🎯$50
Price at call : $38.88 — upside +29%
Today : $149.5 — upside -67%
Expected +29% · Actual +114% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+114.3%
stock +114% · XLV +7%
matured Feb 7, 26
HC Wainwright & Co. ↗
Dec 10, 24
▲ Buy · 🎯$50
Price at call : $41.6 — upside +20%
Today : $149.5 — upside -67%
Expected +20% · Actual +120% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+119.7%
stock +120% · XLV +6%
matured Dec 10, 25
BMO Capital ↗
Dec 6, 24
▲ Outperform · 🎯$62
Price at call : $42.06 — upside +47%
Today : $149.5 — upside -59%
Expected +47% · Actual +115% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 63% (8 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+114.6%
stock +115% · XLV +5%
matured Dec 6, 25
HC Wainwright & Co. ↗
Nov 22, 24
▲ Buy · 🎯$50
Price at call : $46.46 — upside +8%
Today : $149.5 — upside -67%
Expected +8% · Actual +89% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+88.7%
stock +89% · XLV +8%
matured Nov 22, 25
HC Wainwright & Co. ↗
Nov 19, 24
▲ Buy · 🎯$50
Price at call : $38.65 — upside +29%
Today : $149.5 — upside -67%
Expected +29% · Actual +120% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+120.3%
stock +120% · XLV +8%
matured Nov 19, 25
HC Wainwright & Co. ↗
Nov 11, 24
▲ Buy · 🎯$50
Price at call : $43.17 — upside +16%
Today : $149.5 — upside -67%
Expected +16% · Actual +97% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 100% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+96.5%
stock +97% · XLV +4%
matured Nov 11, 25
BMO Capital ↗
Feb 22, 19
▲ Outperform · 🎯$17
Price at call : $8.03 — upside +112%
Today : $149.5 — upside -89%
Expected +112% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on PTGX : 63% (8 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+10.7%
stock +11% · XLV +8%
matured Feb 22, 20
BMO Capital ↗
Mar 27, 18
▲ Outperform · 🎯$13
Price at call : $9.03 — upside +44%
Today : $149.5 — upside -91%
Expected +44% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 63% (8 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+47.1%
stock +47% · XLV +13%
matured Mar 27, 19
BMO Capital ↗
Mar 8, 18
▲ Outperform · 🎯$42
Price at call : $20.23 — upside +108%
Today : $149.5 — upside -72%
Expected +108% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on PTGX : 63% (8 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
-54.9%
stock -55% · XLV +5%
matured Mar 8, 19
BMO Capital ↗
Nov 7, 17
▲ Outperform · 🎯$43
Price at call : $15.97 — upside +169%
Today : $149.5 — upside -71%
Expected +169% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on PTGX : 63% (8 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
-43.3%
stock -43% · XLV +14%
matured Nov 7, 18
BMO Capital ↗
Oct 19, 17
▲ Outperform · 🎯$40
Price at call : $15.93 — upside +151%
Today : $149.5 — upside -73%
Expected +151% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on PTGX : 63% (8 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
-49.5%
stock -50% · XLV +8%
matured Oct 19, 18
BMO Capital ↗
Sep 6, 16
▲ Outperform
Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on PTGX : 63% (8 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+29.7%
stock +30% · XLV +11%
matured Sep 6, 17
Frequently asked questions
Should I buy Protagonist Therapeutics, Inc. stock?
This isn't buy advice. For Protagonist Therapeutics, Inc., the analyst consensus is "Buy", with an average price target of $162 (+8% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Protagonist Therapeutics, Inc.). We show the numbers — you decide.
Is it too late to buy Protagonist Therapeutics, Inc.? How high can it go?
The most bullish analyst target on Protagonist Therapeutics, Inc. is $186 (+24% above today's price); the average is $162. That's the upside they see. Check how reliable those analysts have actually been on Protagonist Therapeutics, Inc. on our site before trusting it.
Is Protagonist Therapeutics, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 12 analysts have a real record on Protagonist Therapeutics, Inc., the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Protagonist Therapeutics, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in PTGX (and why hesitate).
What has Protagonist Therapeutics, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: PTGX performance & returns.
What is the best month to buy PTGX?
The 12 months ranked by the stock's past returns: best & worst month to buy PTGX.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX